N/A
N=552
Association Between SYNTAX Score and Leukoglycemic Index In Patients Wiht Acute Coronary Syndrome
Acute Coronary Syndromes (ACS)
Bottom Line
View on ClinicalTrials.gov: NCT07276256 ↗Enrolled (actual)
552
Serious AEs
—
Results posted
Feb 2026
Primary outcome: Primary: Leukoglycemic Index (LGI) — 1.081; 1.230 mg/dL*cells per mm^3
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- leukoglycemic index calculation (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Kırıkkale University
- Primary completion
- Oct 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Leukoglycemic Index (LGI) |
1.081; 1.230 | — |
Summary
This study looks at people who come to the hospital with acute coronary syndrome, a serious heart condition. When these patients first arrive, doctors take routine blood tests. The investigators use these test results to calculate a value called the leukoglycemic index (LGI), which combines white blood cell count and blood sugar level. The investigators also use a heart imaging score called the SYNTAX score to see how complex their coronary artery disease is.
Patients are divided into two groups based on their SYNTAX scores: one group with lower scores (22 or less), and one with higher scores (above 22). The investigators compare their health data to see if LGI is linked to the severity of their heart disease. The investigators also check if LGI can help predict how complex the disease is. Information like age, family history, and chronic illnesses is collected from patient records and medical interviews.
Eligibility Criteria
Inclusion Criteria
- Adult patients aged 18 years and older
- Patients who underwent coronary angiography due to acute coronary syndrome
Exclusion Criteria
- Patients with diabetes mellitus (Diagnosis based on current use of oral antidiabetic or insulin therapy and/or fasting glucose level ≥126 mg/dL and HbA1c ≥6.5%)
- Patients with atrial fibrillation, history of pacemaker implantation, asthma, pulmonary hypertension, pregnancy, anemia, malignancy, rheumatoid arthritis, or peripheral artery disease
- Obese individuals (defined as body mass index [BMI] >30 kg/m²)
- Patients whose medical records could not be accessed
Data sourced from ClinicalTrials.gov (NCT07276256). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.